Rapastinel
RAP-MD-33
Phase 3 small_molecule terminated
Quick answer
Rapastinel for Depressive Disorder, Major is a Phase 3 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Depressive Disorder, Major
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated